Skip to main content
Schott Pharma logo

Schott Pharma — Investor Relations & Filings

Ticker · 1SXP ISIN · DE000A3ENQ51 LEI · 529900TU48UE99NHEY88 F Manufacturing
Open in API
Filings indexed 134 across all filing types
Latest filing 2026-02-12 Director's Dealing
Country DE Germany
Listing F 1SXP

About Schott Pharma

https://www.schott-pharma.com/en

Schott Pharma is a developer and manufacturer of drug containment solutions and delivery systems for injectable drugs. Serving the pharmaceutical and biotech industries, its portfolio includes prefillable syringes, cartridges, vials, and ampoules. The company provides scientifically proven products designed for the safe storage and administration of medications. Beyond individual components, Schott Pharma offers complete, compatible systems and a range of services, including analytical, development, fill-and-finish, and regulatory support. This integrated approach supports clients from clinical trials through to commercialization, ensuring compatibility across the entire pharma value chain.

Recent filings

Filing Released Lang Actions
SCHOTT Pharma AG & Co. KGaA: Dr. Torsten Derr, buy
Director's Dealing Classification · 1% confidence The document is a formal notification of a transaction in the company's shares by a person discharging managerial responsibilities (Dr. Torsten Derr, a member of the administrative or supervisory body). It explicitly follows the standard format for 'Directors' Dealings' or 'Managers' Transactions' under market abuse regulations, detailing the nature of the transaction (acquisition), the financial instrument (shares), the price, volume, and the date of the transaction. This aligns perfectly with the definition for 'Director's Dealing' (DIRS).
2026-02-12 English
SCHOTT Pharma with positive start to financial year 2026; outlook confirmed
Earnings Release Classification · 1% confidence The document is a corporate news release announcing the Q1 2026 financial results for SCHOTT Pharma. It provides key highlights such as revenue growth, EBITDA margins, and segment performance, and confirms the company's outlook. While it contains financial data, it is structured as an initial announcement (Earnings Release) rather than a full quarterly report or a report publication announcement. It follows the standard format for an earnings release disseminated via a news service (EQS). Q1 2026
2026-02-11 English
Q1 statement / Q1 financial report 2025/2026
Interim / Quarterly Report
2026-02-11 English
Presentation Q1 2026
Investor Presentation Classification · 1% confidence The document is titled 'Results presentation Q1 2026' and contains slides detailing financial performance, business updates, and guidance for the first quarter of the 2026 fiscal year. It includes charts, tables, and commentary from the CEO and CFO, which is characteristic of an investor presentation used during or after an earnings release. It is not a transcript (CT) nor a standalone earnings release (ER), but rather the visual presentation deck provided to investors.
2026-02-11 English
Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved
AGM Information Classification · 1% confidence The document is a corporate news announcement regarding the outcome of an Annual General Meeting (AGM). It confirms that all resolutions were approved, including the dividend payment. While it mentions the AGM, it is a short announcement (under 5,000 characters) summarizing the event and directing readers to the company website for the full voting results and documents, rather than being the official voting results document itself. Therefore, it fits the criteria for a Declaration of Voting Results & Voting Rights Announcement (DVA) as it reports the outcome of the shareholder vote.
2026-02-03 English
Articles of Association of SCHOTT Pharma AG & Co. KGaA (German only)
Governance Information Classification · 1% confidence The document is the 'Satzung' (Articles of Association) of SCHOTT Pharma AG & Co. KGaA. This document outlines the company's legal structure, share capital, governance, and the roles of the general partner and supervisory board. In the context of corporate filings, the Articles of Association are a fundamental governance document that defines the internal rules and structure of the corporation. Among the provided categories, 'Governance Information' (CGR) is the most appropriate classification for documents detailing internal rules, board structure, and governance practices.
2026-02-03 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.